PRRT targets tumours, delivering radiation while sparing surrounding healthy tissues
Radiotherapeutics

Peptide Receptor Radionuclide Therapy (PRRT): A Breakthrough in Treating Gastroenteropancreatic Neuroendocrine Tumours

Peptide Receptor Radionuclide Therapy utilises radiopharmaceuticals to target somatostatin receptor-expressing tumours, improving treatment outcomes significantly.

Peptide Receptor Radionuclide Therapy (PRRT): A Breakthrough in Treating Gastroenteropancreatic Neuroendocrine Tumours Read Post »

, ,
Innovative technologies enhance chronic disease management and improve patient outcomes
Medicine

Innovations in Chronic Disease Management: A New Frontier for Diabetes, Cardiovascular Disease, and Hypertension

Chronic disease management focuses on improving patient outcomes through personalised care, preventative measures, and technological advancements.

Innovations in Chronic Disease Management: A New Frontier for Diabetes, Cardiovascular Disease, and Hypertension Read Post »

, ,
brain scan using Pittsburgh Compound-B (PIB) PET imaging, highlighting amyloid plaques as bright spots within the brain
Nuclear Medicine Imaging

The Discovery and Development of Pittsburgh Compound-B (PIB): A Breakthrough in Alzheimer’s Disease Research

Pittsburgh Compound-B allows researchers to visualise amyloid plaques in the brain, aiding in Alzheimer’s disease diagnosis and study.

The Discovery and Development of Pittsburgh Compound-B (PIB): A Breakthrough in Alzheimer’s Disease Research Read Post »

, , ,
Scroll to Top